[On lithium treatment of the chronic course types of manic-depressive diseases].
D000928:Antidepressive Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy*; D002214:Capsules; D002254:Carbonates / Q000008:administration & dosage / Q000009:adverse effects; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008094:Lithium / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D008297:Male; D010783:Photometry; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000928:Antidepressive Agents; D002214:Capsules; D002254:Carbonates; D014149:Tranquilizing Agents; D008094:Lithium
Zur Lithiumbehandlung der chronischen Verlaufsformen des manisch-depressiven Krankheitsgeschehens.